XML 36 R11.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities      
Net income $ 296,396 $ 107,267 $ 68,978
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization expense 68,241 69,618 59,132
Amortization of operating lease right-of-use assets 36,969 33,235 29,394
Loss on impairment of assets 0 3,073 144
(Gain) loss on sales and disposal of subsidiaries, property and equipment and leases, net (5,103) 9,603 (11,146)
Non-cash interest expense 1,541 1,018 1,591
Non-cash share-based compensation expense 7,843 7,114 8,776
Bad debt expense 55,753 43,733 21,972
Deferred income taxes (38,524) (55,856) (530)
Unrealized foreign currency exchange (gain) loss (53,109) 75,488 13,907
Non-cash loss from non-income tax contingencies 0 0 743
Loss on debt extinguishment 31 0 0
Other, net (2,910) 283 6,086
Changes in operating assets and liabilities:      
Receivables (57,975) (51,738) (27,524)
Prepaid expenses and other assets (15,188) 2,621 4,800
Accounts payable and accrued expenses 4,748 (4,260) (10,464)
Income tax receivable/payable, net (30,612) 23,298 31,330
Deferred revenue and other liabilities (35,368) (13,717) (18,959)
Net cash provided by operating activities 232,733 250,780 178,230
Cash flows from investing activities      
Purchase of property and equipment (71,886) (56,437) (52,756)
Expenditures for deferred costs (17) (20) (312)
Receipts from sales of property and equipment 17,964 274 468
Net (payments) receipts related to sales of discontinued operations (3,610) 4,265 82,946
Net cash (used in) provided by investing activities (57,549) (51,918) 30,346
Cash flows from financing activities      
Proceeds from issuance of long-term debt, net of original issue discount 155,146 153,772 496,253
Payments on long-term debt (215,560) (243,438) (433,705)
Payments to purchase noncontrolling interests 0 (123) 0
Payments of special dividends, special cash distributions, and dividend equivalent rights (1,714) (112,478) (253,188)
Proceeds from exercise of stock options 230 2,308 13,216
Payments to repurchase common stock (102,067) 0 (282,151)
Withholding of shares to satisfy tax withholding for vested stock awards and exercised stock options (2,894) (623) (1,994)
Payment of debt issuance costs (79) (1,306) 0
Net cash used in financing activities (166,938) (201,888) (461,569)
Effects of exchange rate changes on Cash and cash equivalents and Restricted cash (7,546) 6,641 1,202
Change in cash included in current assets held for sale 257 (502) 0
Net change in Cash and cash equivalents and Restricted cash 957 3,113 (251,791)
Cash and cash equivalents and Restricted cash at beginning of period 96,897 93,784 345,575
Cash and cash equivalents and Restricted cash at end of period $ 97,854 $ 96,897 $ 93,784